Your browser doesn't support javascript.
loading
The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features.
Jakstas, Tomas; Bartnykaite, Agne; Padervinskis, Evaldas; Vegiene, Aurelija; Juozaityte, Elona; Uloza, Virgilijus; Ugenskiene, Rasa.
Afiliación
  • Jakstas T; Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania. tomas.jakstas@lsmu.lt.
  • Bartnykaite A; Oncology Research Laboratory, Oncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Padervinskis E; Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Vegiene A; Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Juozaityte E; Oncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Uloza V; Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Ugenskiene R; Oncology Research Laboratory, Oncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.
BMC Cancer ; 24(1): 214, 2024 Feb 15.
Article en En | MEDLINE | ID: mdl-38360622
ABSTRACT

BACKGROUND:

Laryngeal squamous cell carcinoma (LSCC) is one of the most common types of cancer in the upper respiratory tract. It is well-known that it has a high mortality rate and poor prognosis in advanced stages. There are well-known risk factors for LSCC, though new specific and prognostic blood-based markers for LSCC development and prognosis are essential. The current study aimed to evaluate the impact of four different single nucleotide polymorphisms (SNPs), E2F1 (rs3213183 and rs3213180) and E2F2 (rs2075993 and rs3820028), on LSCC development, morphological features, and patient 5-year survival rate.

METHODS:

A total of 200 LSCC patients and 200 controls were included in this study; both groups were matched by age and sex. In the present study, we analyzed four single nucleotide polymorphisms (SNPs) in the genes E2F1 (rs3213183 and rs3213180) and E2F2 (rs2075993 and rs3820028) and evaluated their associations with the risk of LSCC development, its clinical and morphological manifestation, and patients 5-year survival rate. Genotyping was carried out using RT-PCR.

RESULTS:

None of the analyzed SNPs showed a direct association with LSCC development. E2F2 rs2075993 G allele carriers (OR = 4.589, 95% CI 1.050-20.051, p = 0.043) and rs3820028 A allele carriers (OR = 4.750, 95% CI 1.088-20.736, p = 0.038) had a statistically significantly higher risk for poor differentiated or undifferentiated LSCC than non-carriers. E2F1 rs3213180 GC heterozygotes were found to have a 3.7-fold increased risk for lymph node involvement (OR = 3.710, 95% CI 1.452-9.479, p = 0.006). There was no statistically significant association between investigated SNPs and patient 5-year survival rate.

CONCLUSIONS:

The present study indicates that E2F2 rs2075993 and rs3820028 impact LSCC differentiation, whereas E2F1 rs3213180 - on lymph node involvement.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Laríngeas / Factor de Transcripción E2F1 / Factor de Transcripción E2F2 / Carcinoma de Células Escamosas de Cabeza y Cuello Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Lituania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Laríngeas / Factor de Transcripción E2F1 / Factor de Transcripción E2F2 / Carcinoma de Células Escamosas de Cabeza y Cuello Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Lituania Pais de publicación: Reino Unido